Radiation Dose Aspects of Hepatic Artery Infusion Chemotherapy in Uveal Melanoma Patients with Liver Metastases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-086X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Radiation Dose Aspects of Hepatic Artery Infusion Chemotherapy in Uveal Melanoma Patients with Liver Metastases ; volume:45 ; number:6 ; day:18 ; month:4 ; year:2022 ; pages:841-845 ; date:6.2022
CardioVascular and interventional radiology ; 45, Heft 6 (18.4.2022), 841-845, 6.2022
- Urheber
-
Zensen, Sebastian Stefan
Opitz, Marcel K.
Ludwig, Johannes M.
Haubold, Johannes
Richly, Heike
Siveke, Jens T.
Theysohn, Jens M.
Forsting, Michael
Bos, Denise
Schaarschmidt, Benedikt M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00270-022-03130-1
- URN
-
urn:nbn:de:101:1-2022072508152785860552
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zensen, Sebastian Stefan
- Opitz, Marcel K.
- Ludwig, Johannes M.
- Haubold, Johannes
- Richly, Heike
- Siveke, Jens T.
- Theysohn, Jens M.
- Forsting, Michael
- Bos, Denise
- Schaarschmidt, Benedikt M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
Detection of metastases using circulating tumour DNA in uveal melanoma
Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases
The biology of uveal melanoma
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
Disseminated gestational choriocarcinoma presenting with hepatic and uveal metastases, hook effect, and choriocarcinoma syndrome
Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma
Epidemiology of uveal melanoma in Brazil
Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
Detection of metastases using circulating tumour DNA in uveal melanoma
Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases
The biology of uveal melanoma
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
Disseminated gestational choriocarcinoma presenting with hepatic and uveal metastases, hook effect, and choriocarcinoma syndrome
Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma
Epidemiology of uveal melanoma in Brazil
Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
Detection of metastases using circulating tumour DNA in uveal melanoma
Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases
The biology of uveal melanoma
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
Disseminated gestational choriocarcinoma presenting with hepatic and uveal metastases, hook effect, and choriocarcinoma syndrome
Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma
Epidemiology of uveal melanoma in Brazil